InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
T+90 hit rate
67%
T+90 mean return
+3.8%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Warner Robert Keith, Director. Director active across 2 companies, notably RxSight, Inc.. In total, 13 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €1.1m. Activity tracked since 3 August 2021. The latest transaction was disclosed on 24 April 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations13 total
12,149 sharesCommon StockSEC:0001127602-25-005764:0
2,554 sharesCommon StockSEC:0000950170-24-071326:0
4,126 shares@ US$42.4150.0% of flowCommon StockSEC:0001127602-24-017136:0
4,126 shares@ US$42.4150.0% of flowCommon StockSEC:0001127602-24-013480:0
16,530 shares@ US$42.370857.6% of flowCommon StockSEC:0000950170-24-003339:0
14,502 shares@ US$35.009442.4% of flowCommon StockSEC:0001209191-23-058376:0
5,731 shares0Common StockSEC:0001209191-23-034345:0
2,412 shares0Common StockSEC:0001127602-23-016356:0
8,624 shares0Common StockSEC:0001209191-22-034397:0
2,420 shares0Common StockSEC:0001127602-22-015866:0
3,191 shares0Common StockSEC:0001562180-22-002325:0
5,733 shares0Common StockSEC:0000899243-21-031808:0
5,733 shares0Common StockSEC:0000899243-21-031808
13 of 13 declarations
About Warner Robert Keith
Robert Keith Warner is a Board Member at RxSight, Inc. and Inari Medical, Inc. In this role, he participates in corporate governance and strategic decision-making. Robert Keith Warner brings valuable expertise in the medical device field, contributing to innovation and healthcare improvement. His commitment to excellence and corporate responsibility is an asset to the boards of these companies.
